169 related articles for article (PubMed ID: 27270457)
1. ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
Renault AL; Lesueur F; Coulombe Y; Gobeil S; Soucy P; Hamdi Y; Desjardins S; Le Calvez-Kelm F; Vallée M; Voegele C; ; Hopper JL; Andrulis IL; Southey MC; John EM; Masson JY; Tavtigian SV; Simard J
PLoS One; 2016; 11(6):e0156820. PubMed ID: 27270457
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.
Solyom S; Aressy B; Pylkäs K; Patterson-Fortin J; Hartikainen JM; Kallioniemi A; Kauppila S; Nikkilä J; Kosma VM; Mannermaa A; Greenberg RA; Winqvist R
Sci Transl Med; 2012 Feb; 4(122):122ra23. PubMed ID: 22357538
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.
Novak DJ; Sabbaghian N; Maillet P; Chappuis PO; Foulkes WD; Tischkowitz M
Breast Cancer Res Treat; 2009 Sep; 117(2):453-9. PubMed ID: 18695986
[TBL] [Abstract][Full Text] [Related]
4. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
5. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Hamdi Y; Soucy P; Adoue V; Michailidou K; Canisius S; Lemaçon A; Droit A; Andrulis IL; Anton-Culver H; Arndt V; Baynes C; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brenner H; Broeks A; Burwinkel B; Chang-Claude J; ; Couch FJ; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Devilee P; Dörk T; Dos-Santos-Silva I; Eriksson M; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Goldberg MS; González-Neira A; Grenaker-Alnæs G; Guénel P; Haeberle L; Haiman CA; Hamann U; Hallberg E; Hooning MJ; Hopper JL; Jakubowska A; Jones M; Kabisch M; Kataja V; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Maranian M; Margolin S; Marme F; Milne RL; Neuhausen SL; Nevanlinna H; Neven P; Olswold C; Peto J; Plaseska-Karanfilska D; Pylkäs K; Radice P; Rudolph A; Sawyer EJ; Schmidt MK; Shu XO; Southey MC; Swerdlow A; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Van Den Ouweland AM; Wang Q; Winqvist R; ; Zheng W; Benitez J; Chenevix-Trench G; Dunning AM; Pharoah PD; Kristensen V; Hall P; Easton DF; Pastinen T; Nord S; Simard J
Oncotarget; 2016 Dec; 7(49):80140-80163. PubMed ID: 27792995
[TBL] [Abstract][Full Text] [Related]
6. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
7. Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.
Cecener G; Guney Eskiler G; Egeli U; Tunca B; Alemdar A; Gokgoz S; Tasdelen I
Mol Biol Rep; 2016 Nov; 43(11):1273-1284. PubMed ID: 27573125
[TBL] [Abstract][Full Text] [Related]
8. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
9. RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.
Le Calvez-Kelm F; Oliver J; Damiola F; Forey N; Robinot N; Durand G; Voegele C; Vallée MP; Byrnes G; Registry BC; Hopper JL; Southey MC; Andrulis IL; John EM; Tavtigian SV; Lesueur F
PLoS One; 2012; 7(12):e52374. PubMed ID: 23300655
[TBL] [Abstract][Full Text] [Related]
10. Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families.
Solyom S; Patterson-Fortin J; Pylkäs K; Greenberg RA; Winqvist R
Breast Cancer Res Treat; 2010 Feb; 120(1):165-8. PubMed ID: 19572197
[TBL] [Abstract][Full Text] [Related]
11. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
12. Germline RAP80 mutations and susceptibility to breast cancer.
Akbari MR; Ghadirian P; Robidoux A; Foumani M; Sun Y; Royer R; Zandvakili I; Lynch H; Narod SA
Breast Cancer Res Treat; 2009 Jan; 113(2):377-81. PubMed ID: 18306035
[TBL] [Abstract][Full Text] [Related]
13. Germline RECQL mutations are associated with breast cancer susceptibility.
Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
[TBL] [Abstract][Full Text] [Related]
14. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
Mantere T; Tervasmäki A; Nurmi A; Rapakko K; Kauppila S; Tang J; Schleutker J; Kallioniemi A; Hartikainen JM; Mannermaa A; Nieminen P; Hanhisalo R; Lehto S; Suvanto M; Grip M; Jukkola-Vuorinen A; Tengström M; Auvinen P; Kvist A; Borg Å; Blomqvist C; Aittomäki K; Greenberg RA; Winqvist R; Nevanlinna H; Pylkäs K
Sci Rep; 2017 Apr; 7(1):681. PubMed ID: 28386063
[TBL] [Abstract][Full Text] [Related]
15. Mutation and association analysis of GEN1 in breast cancer susceptibility.
Turnbull C; Hines S; Renwick A; Hughes D; Pernet D; Elliott A; Seal S; Warren-Perry M; Gareth Evans D; Eccles D; ; Stratton MR; Rahman N
Breast Cancer Res Treat; 2010 Nov; 124(1):283-8. PubMed ID: 20512659
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of germline mutations in breast cancer genes: RECQL.
Bowden AR; Tischkowitz M
Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
